MONTRONI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.648
EU - Europa 1.632
AS - Asia 1.304
SA - Sud America 218
AF - Africa 37
OC - Oceania 8
Totale 5.847
Nazione #
US - Stati Uniti d'America 2.627
SG - Singapore 511
SE - Svezia 370
UA - Ucraina 289
VN - Vietnam 263
RU - Federazione Russa 233
CN - Cina 205
BR - Brasile 166
DE - Germania 166
IE - Irlanda 148
DK - Danimarca 101
HK - Hong Kong 96
FR - Francia 95
GB - Regno Unito 73
FI - Finlandia 72
KR - Corea 66
TR - Turchia 66
IT - Italia 42
IN - India 21
AR - Argentina 16
BE - Belgio 15
BD - Bangladesh 14
ZA - Sudafrica 14
IQ - Iraq 11
CA - Canada 9
CO - Colombia 9
MA - Marocco 8
MX - Messico 7
EC - Ecuador 6
VE - Venezuela 6
AT - Austria 5
CI - Costa d'Avorio 5
JO - Giordania 5
MY - Malesia 5
NL - Olanda 5
PL - Polonia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
KE - Kenya 4
NZ - Nuova Zelanda 4
PE - Perù 4
PY - Paraguay 4
UZ - Uzbekistan 4
CL - Cile 3
EG - Egitto 3
GE - Georgia 3
JP - Giappone 3
KZ - Kazakistan 3
LB - Libano 3
PH - Filippine 3
RO - Romania 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
ES - Italia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PK - Pakistan 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
BB - Barbados 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
ME - Montenegro 1
MT - Malta 1
RS - Serbia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 5.847
Città #
Singapore 352
Chandler 347
Jacksonville 286
Ashburn 226
Boardman 158
Dublin 147
Wilmington 142
Fairfield 120
San Jose 98
Hong Kong 93
Dallas 86
Ho Chi Minh City 75
Ann Arbor 70
Seattle 70
Houston 67
San Mateo 66
Woodbridge 64
Beijing 60
Hanoi 58
Lawrence 58
Princeton 58
Des Moines 52
Lauterbourg 50
Hefei 49
The Dalles 49
New York 45
Los Angeles 41
Buffalo 31
Moscow 30
San Diego 25
Cambridge 21
Brussels 15
Helsinki 15
Da Nang 13
Chicago 11
Haiphong 11
Orem 11
São Paulo 10
Auburn Hills 9
Johannesburg 9
Phoenix 9
Seoul 9
Chennai 8
Council Bluffs 8
Ankara 7
Norwalk 7
Santa Clara 7
Washington 7
Rio de Janeiro 6
Stockholm 6
Thái Bình 6
Abidjan 5
Amman 5
Montreal 5
Shanghai 5
Warsaw 5
Bogotá 4
Bến Tre 4
Cape Town 4
Hanover 4
Hải Dương 4
London 4
Nairobi 4
Nuremberg 4
San Francisco 4
Tashkent 4
Baghdad 3
Biên Hòa 3
Boston 3
Brasília 3
Charlotte 3
Denver 3
Dhaka 3
Guangzhou 3
Karbala 3
Kuala Lumpur 3
Lima 3
Marche 3
Montevideo 3
Munich 3
Ninh Bình 3
Porto Alegre 3
Pune 3
Quanzhou 3
Rome 3
São João del Rei 3
Tbilisi 3
Tokyo 3
Torre Annunziata 3
Wuhan 3
Almaty 2
Anápolis 2
Asunción 2
Auckland 2
Baku 2
Barranquilla 2
Brooklyn 2
Cachoeiro de Itapemirim 2
Cairo 2
Can Tho 2
Totale 3.435
Nome #
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 170
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 162
Anticardiolipin antibodies expression in psoriasis 161
Higly active antiretroviral therapy induces specific changes in effector and central memory T cell sub-populations 148
Diagnosis of Immediate-Type ß-Lactam Allergy In Vitro by Flow-Cytometric Basophil Activation Test and Sulfi doleukotriene Production: a Multicenter Study. 136
Comparsa di polmonite in soggetto con storia recente di inappetenza, disfagia, calo ponderale, ed eritema diffuso. 130
Effects of cryopreservation on lymphocyte immunophenotype and function 128
Abnormal intracellular kinetics of cell –cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biological link between immune activation, accelerated T- cell turnover and high levels of apoptosis 127
Diagnosi sierologica nelle malattie autoimmuni non organo-specifiche. 126
Exogenous IL-2 administration corrects the cell cycle perturbation of lymphocytes from HIV-infected individuals 124
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? 123
Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults; results of a 48-week open-label, equivalence trial (CAN 3014) 122
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy. 121
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome. 120
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART. 119
Il ruolo del Medico di Medicina Generale nella diagnosi precoce della malattia da HIV. 116
Interruption of antiretroviral therapy is associated with increased plasma cystatin C. 115
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. 109
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naïve for Antiretrovirals 109
Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. 108
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy. 106
I vaccini, da Jenner ai vaccini a DNA 105
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. 104
Specific changes in the post-translational regulation of nucleolin in lymphocytes from patients infected with human immunodeficiency virus 104
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. 102
Major clinical outcomes in antiretroviral therapy (ART)-naïve participants and in those not receiving ART at baseline in the SMART study. 101
Unscheduled cyclin B expression and p34 cdc2 activation in T-lymphocytes from HIV patients 99
Genotypic Resistance Tests for the Management of Structured Therapeutic Interruptions after Multiple Drug Failure: Prosecution 99
Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization. 99
HIV-induced abnormalities in myelopoiesis and their recovery following antiretroviral therapy 98
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. 94
Sexual behaviour of heterosexual individuals with HIV infection naïve for antiretroviral therapy in Italy . 94
Lo studio fenotipico delle cellule mononucleate, linee guida all'impiego clinico, alla lettura ed all'interpretazione nelle diverse condizioni morbose. 93
Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status 91
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures. 90
Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replicatio 90
Lo studio fenotipico di linfociti e altre cellule mononucleate. 90
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 90
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. 90
Impact of Higly Active Antiretroviral Therapy on the Presenting Features and Outcome of Patients with Acquired Immunodeficiency Syndrome-Related Kaposi Sarcoma 89
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. 88
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis. 87
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients. 87
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. 87
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis. 86
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. 86
Loss of CD127 (Interleukin-7 receptor) expression defines an expansion of “effector memory” CD8+Tcells in HIV-infected patients 84
Low prevalence of primary mutations associated with drug resistance in antiviral-naïve patients at therapy initiation 79
Il paziente adulto con immunodeficienza. 78
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina. 78
Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from tha italian cohort of antiretroviral-naïve patients study 78
Identikit della immunodeficienza da HIV. 73
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. 71
Il ruolo del Mmg nella diagnosi precoce della malattia da HIV. 68
Infezione da HIV-1. 66
La diagnosi immunologica delle Malattie Autoimmuni non Organo Specifiche 64
L’immunoricostituzione, un paesaggio dai mutevoli confini 63
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the I.Co.N.A study 61
Totale 5.886
Categoria #
all - tutte 23.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.422


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021221 0 0 0 0 0 0 0 0 0 64 106 51
2021/2022441 13 96 2 61 8 21 8 43 26 56 23 84
2022/2023948 88 72 67 95 104 173 0 65 235 1 24 24
2023/2024404 85 11 17 73 70 62 8 8 0 4 12 54
2024/2025688 49 66 44 4 11 43 31 15 204 34 53 134
2025/20261.718 86 121 53 166 274 161 390 211 146 110 0 0
Totale 5.886